ArticleBlood2015

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Byung-Sik Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.